Answers are grounded in this paper and cite their sources.
Introduction: One of the most prevalent conditions in Western societies is gastroesophageal reflux disease (GERD). In Switzerland, the standard treatment for GERD is proton pump inhibitor (PPI)-based medical management, but surgical options such as Nissen fundoplication and the MSA system are available. RefluxStop is a novel device that offers an alternative solution. The purpose of this report is to evaluate the cost-effectiveness of RefluxStop compared to PPIs and existing surgical treatments.
No takes yet. Share an insight, caveat, or question.
Harper et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: